Omzo vs Strut Health: Which GLP-1 Program Fits You Best
Quick verdict: Omzo vs Strut Health
Omzo and Strut Health both offer clinician-reviewed GLP-1 options, but the choice is clear early: pick Omzo if you want personalized compounded injections and clinician-guided plans starting at $179; pick Strut Health if you need an oral-focused program with plans starting from $199 per month. This article compares the two directly on form of medication, pricing and billing, clinical model, shipping and policies, and regulatory notes.
Explore Omzo clinician-guided plans
Key difference 1: Medication form and specialization
Omzo emphasizes compounded semaglutide and tirzepatide delivered as one weekly injection option under a clinician-guided program. Strut Health specializes in oral-based GLP-1 options, including oral semaglutide lozenges taken once daily, and highlights an oral-focused clinical team. This is the primary functional distinction: Omzo centers on injectable compounded therapies and branded prescription routing when appropriate, while Strut Health centers on oral semaglutide and lozenge protocols.
Key difference 2: Pricing structure and presentation
Both providers present starting prices but in different formats. Omzo lists semaglutide starting at $179 and tirzepatide starting at $279, describing personalized, clinician-guided compounding programs. Strut Health lists pricing from $199 per month for oral GLP-1 programs and promotes simple billing language like free shipping and cancel anytime. The sources supply these figures only; do not assume coverage, discounts, or insurance handling beyond the stated facts.
Clinical model and provider review
Omzo connects users with licensed U.S. clinicians and states that clinical services are provided by third party clinician networks who determine eligibility and prescribe based on professional judgment. Omzo also notes its compounded medications are produced by state-licensed sterile compounding pharmacies and that these compounded drugs are not FDA-approved. Strut Health provides guided consultations with an oral specialization and notes compounded semaglutide is prescribed based on medical necessity and a licensed physician decision. Both stress clinician oversight and prescription-level determinations.
See Strut Health oral GLP-1 options
Shipping, policies, and program features
Omzo advertises fast, discreet delivery and calls out FSA and HSA eligibility. Omzo also clarifies it does not sell or ship branded medications; if a branded product is prescribed the patient fills it at their chosen pharmacy. Strut Health highlights free shipping, no hidden fees, and a cancel anytime approach for its oral plans. Those are the explicit shipping and policy claims captured from each provider.
Regulatory and safety notes
Both sources include the important regulatory qualifier that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Omzo explicitly says its compounded drugs are not FDA-approved and have not been evaluated by the FDA. Strut Health likewise notes compounded semaglutide is prepared at U.S.-licensed compounding pharmacies and that compounded medications are not FDA-approved. Both recommend clinician evaluation and preserve medical necessity or provider judgment requirements.
Comparison table: Omzo vs Strut Health
| Criteria | Omzo | Strut Health |
|---|---|---|
| Primary medication forms | Compounded semaglutide and tirzepatide injections; option for prescriptions for branded meds | Oral semaglutide lozenges and oral-focused options |
| Starting price shown | Semaglutide starting at $179; tirzepatide starting at $279 | From $199 per month |
| Clinical oversight | Clinician-guided plans reviewed by licensed U.S. providers; third party clinician networks | Guided consultations; medical necessity required for some prescriptions |
| Shipping and billing notes | Fast, discreet delivery; FSA and HSA eligible; Omzo pays partner pharmacies for compounded meds | Free shipping; no hidden fees; cancel anytime |
| Regulatory note | Compounded meds not FDA-approved | Compounded meds not FDA-approved |
| Best for | People who confirm eligibility, medication, total cost, renewal terms and state availability before enrollment | Users specifically seeking oral plans |
Check Omzo compounded injection options
How to choose between Omzo and Strut Health
Use the distinctions above to match the program to your priorities. If your priority is a clinician-guided compounding program with injectable semaglutide or tirzepatide presented with start prices like $179 and $279, Omzo fits that profile and explicitly describes clinician review and compounding pharmacy processes. If you need an oral semaglutide pathway with daily lozenges, a program focused on oral delivery, and monthly pricing from $199, Strut Health is the clearly stated specialization.
Compare Strut Health oral plan details
Final thoughts: Omzo vs Strut Health
Omzo and Strut Health both rely on licensed clinicians and include the regulatory qualifier that compounded medications are not FDA-approved. The decisive factors are medication form and billing model: Omzo highlights compounded injections and clinician-guided plans starting at $179 while Strut Health highlights oral semaglutide and plans from $199 per month. There is no supplied evidence here about clinical outcomes, insurance coverage, or long term guarantees beyond the captured statements.
Choose Omzo if…
you want clinician-guided compounded semaglutide or tirzepatide with weekly injection options, starting price points listed as starting at $179 for semaglutide and $279 for tirzepatide, and a program described as reviewed by licensed U.S. providers.
Choose Strut Health if…
you are specifically seeking an oral-focused GLP-1 program with oral semaglutide lozenges, guided consultations, and pricing presented as from $199 per month, along with free shipping and a cancel anytime policy.